Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

3-Deazaadenosine (hydrochloride)

3-Deazaadenosine (hydrochloride) is an inhibitor of S-adenosylhomocysteine hydrolase, with a Ki of 3.9 μM; 3-Deazaadenosine has anti-inflammatory, anti-proliferative and anti-HIV activity.

Product Specifications

CAS Number

[86583-19-9]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

HIV; S-adenosylhomocysteine hydrolase (SAHH)

Type

Reference compound

Related Pathways

Anti-infection; Epigenetics; Metabolic Enzyme/Protease

Applications

COVID-19-anti-virus

Field of Research

Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/3-Deazaadenosine_hydrochloride.html

Purity

99.67

Solubility

DMSO : 41.67 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mL

Smiles

O[C@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C3=C(C(N)=NC=C3)N=C2.Cl

Molecular Formula

C11H15ClN4O4

Molecular Weight

302.72

Precautions

H302, H315, H319, H335

References & Citations

[1]Gordon RK, et al. Anti-HIV-1 activity of 3-deaza-adenosine analogs. Inhibition of S-adenosylhomocysteine hydrolase and nucleotide congeners. Eur J Biochem. 2003 Sep;270 (17) :3507-17.|[2]Jeong SY, et al. 3-deazaadenosine, a S-adenosylhomocysteine hydrolase inhibitor, has dual effects on NF-kappaB regulation. Inhibition of NF-kappaB transcriptional activity and promotion of IkappaBalpha degradation. J Biol Chem. 1999 Jul 2;274 (27) :18981-8.|[3]Sedding DG, et al. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling. Circ Res. 2009 May 22;104 (10) :1192-200.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

HIV-1

Citation 01

BioRxiv. 2024 May 18.|J Clin Invest. 2025 July 22.|Water Biol Secur. 2025 Apr 18.|Am J Physiol Cell Physiol. 2024 Mar 1;326 (3) :C684-C697.|Arch Toxicol. 2021 Jan;95 (1) :299-309.|Biomolecules. 2025 Aug 18;15 (8) :1188.|BMC Biol. 2024 May 3;22 (1) :104.|Cancer Cell Int. 2023 Dec 18;23 (1) :330.|Cancer Res. 2021 Sep 15;81 (18) :4778-4793.|Cell Biol Int. 2025 Jun;49 (6) :674-691.|Cell Death Dis. 2025 Oct 27;16 (1) :767.|Cell Mol Biol Lett. 2024 Jul 3;29 (1) :97.|Cell Rep. 2021 Jan 5;34 (1) :108580.|Cell Signal. 2025 Jan 22:111623.|Environ Pollut. 2023 Aug 15;331 (Pt 2) :121798.|Eur J Pharmacol. 2024 Dec 31:177247.|Exp Cell Res. 2024 Aug 27:114226.|Exp Cell Res. 2025 Mar 25:114538.|Genomics. 2022 Jul;114 (4) :110424.|Inflammation. 2025 Nov 7.|Int J Biol Sci. 2023 Jan 1;19 (2) :593-609.|J Cancer. 2023 Apr 17;14 (7) :1117-1131.|J Neurosci. 2023 Mar 1;43 (9) :1456-1474.|Oncogene. 2024 Apr;43 (17) :1288-1302.|Research Square Print. 2022 May.|Transpl Immunol. 2024 Jul 10:102083.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

MAGOH2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
K1257605 3x 1.0 µg

MAGOH2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

Sign In for Pricing
View Details
pCDNA3.1-3XHA-PELI1-Y154F-T264A Plasmid
PVT30130 2 µg

pCDNA3.1-3XHA-PELI1-Y154F-T264A Plasmid

Sign In for Pricing
View Details
Sclt1 sgRNA CRISPR Lentivector (Rat) (Target 3)
K6300004 1.0 µg DNA

Sclt1 sgRNA CRISPR Lentivector (Rat) (Target 3)

Sign In for Pricing
View Details
MPST Human Gene Knockout Kit (CRISPR)
KN402466 1 Kit

MPST Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
Prolylisoleucine
597376 100.0mg

Prolylisoleucine

Sign In for Pricing
View Details
Lentiviral human GFPT2 sgRNA gene knockout kit - Lentiviral human GFPT2 sgRNA gene knockout kit (plasmid)
GTR15383180 1 Vial

Lentiviral human GFPT2 sgRNA gene knockout kit - Lentiviral human GFPT2 sgRNA gene knockout kit (plasmid)

Sign In for Pricing
View Details